INVEGA SUSTENNA® Common Dosing and Administration Topics
Switching from Other Antipsychotics
From Oral Antipsychotic to INVEGA SUSTENNA® – General Overview
Consistent with the INVEGA SUSTENNA® Prescribing Information:
- There are no systematically collected data to specifically address switching patients with schizoaffective disorder from other antipsychotics to INVEGA SUSTENNA®, or concerning concomitant administration with other antipsychotics.
- For patients who have never taken oral paliperidone or oral or injectable risperidone, tolerability should be established with oral paliperidone or oral risperidone prior to initiating treatment with INVEGA SUSTENNA®.
- Previous oral antipsychotics can be gradually discontinued at the time of initiation of treatment with INVEGA SUSTENNA®. Recommended initiation of INVEGA SUSTENNA® is with a dose of 234 mg followed by 156 mg one week later, both administered in the deltoid muscle.
For illustrative displays of this dosing scenario, please click the link(s) below.